MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0000603
Osper Formulations Private Limited - pharma in Rohtak, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.03 Cr
▲ 11% YoY
Net profit · FY 2025
₹4.33 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹1.14 Cr
EBITDA margin 10.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹19 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
33
Provident fund records
About Osper Formulations Private Limited
Data last updated:
Osper Formulations Private Limited is a private limited company based in Rohtak, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100HR2013PTC049505. Its GSTIN is 02AABCO8545N1Z6 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Suresh Kumar Gupta and Raj Bala Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No 1376A/19 Civil Road (HUDA Complex), Rohtak, Haryana, India – 124001.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.03 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹4.33 Lakh (net margin 0.4%) and EBITDA of ₹1.14 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 4% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹19 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
Osper Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0000603). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website osperindia.in.
Company Details of Osper Formulations Private Limited
CIN U24100HR2013PTC049505
Registration Number 049505
Incorporation Date 10 June 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0000603
Recognitions & Rankings of Osper Formulations
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No 1376A/19 Civil Road (HUDA Complex), Rohtak, Haryana, India – 124001
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Osper Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Osper Formulations Private Limited
The main business activity of Osper Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Osper Formulations Private Limited FY 2024 filings available
Osper Formulations Private Limited reported revenue of ₹11.03 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹11.03 Cr ▲ 11%
Net profit · FY 2025
₹4.33 Lakh margin 0.4%
EBITDA · FY 2025
₹1.14 Cr margin 10.3%
Compounded Annual Growth Rate (CAGR) of Osper Formulations Private Limited
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 3%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 7%
5 years · compounded
▲ 1%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 11% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Osper Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Osper Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Osper Formulations are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Osper Formulations Private Limited
Osper Formulations has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Gupta | Director | 10 Jun 2013 | 13 Years 4 Months | Current |
| Raj Bala Gupta | Director | 10 Jun 2013 | 13 Years 4 Months | Current |
Peer Comparison of Osper Formulations Private Limited
Osper Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BMW Pharmaco India Private Limited | ₹11.11 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Medicamen Life Sciences Private Limited | ₹11.09 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | New Delhi, Delhi, India |
| Rowez Life Sciences Private Limited | ₹11.08 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Kochi, Kerala, India |
| RN Chemicals & Pharmaceutical Private Limited | ₹11.08 Cr (FY 2025) | •••• | •••• | 970.0% | •••• | Solan, Himachal Pradesh, India |
| Pilco Healthcare Private Limited | ₹11.07 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Kanpur, Uttar Pradesh, India |
| Osper Formulations Private Limited this company | ₹11.03 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Rohtak, Haryana, India |
| Texas Pharmaceuticals Private Limited | ₹11.03 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Karnal, Haryana, India |
| Vignesh Life Sciences Pvt Ltd | ₹11.02 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Hyderabad, Telangana, India |
| Alenvision Pharma Private Limited | ₹11.01 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
| Eastern Chemical Industrias Pvt Ltd | ₹11 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Cuttack, Odisha, India |
| Nav2dx Medicare Private Limited | ₹11 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Osper Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Osper Formulations Private Limited
Osper Formulations Private Limited is audited by KSPN & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KSPN & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Osper Formulations Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Osper Formulations Private Limited
Open charges
₹19 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 2025 | Sidbi | ₹1 Cr | Open |
| 23 Feb 2024 | Sidbi | ₹2.22 Cr | Open |
| 18 Aug 2022 | Others | ₹5.7 Cr | Open |
| 14 Dec 2021 | Others | ₹47 Lakh | Open |
| 11 Jun 2020 | Others | ₹94 Lakh | Open |
Total charge records: 7 View all charges
Legal Cases of Osper Formulations Private Limited
Osper Formulations Private Limited has 2 court cases on record: 2 filed by Osper Formulations. All cases are disposed. Status as checked between 29 Sep 2026 and 01 Oct 2026.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Execution petition | Filed by the company against Strathspey Labs Private Limited | Disposed |
| High Court of Jammu and Kashmir and Ladakh | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Osper Formulations Private Limited
Osper Formulations Private Limited has a workforce of 33 employees as of Mar 10, 2025.
Employee count
33
Active EPFO establishments
1
Employee growth
153.85%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Osper Formulations Private Limited
Osper Formulations Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Raj Bala Gupta was appointed as Director on 10 Jun 2013.
Charges
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 101104182 was registered on 14 May 2025.
AGM
Osper Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Osper Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Sidbi amounted to Rs. 2.22 Cr with Charge ID 100934704 was registered on 23 Feb 2024.
Charges
A charge with Others amounted to Rs. 5.70 Cr with Charge ID 100615105 was registered on 18 Aug 2022.
Charges
A charge with Others amounted to Rs. 0.47 Cr with Charge ID 100521547 was registered on 14 Dec 2021.
Charges
A charge with Others amounted to Rs. 0.94 Cr with Charge ID 100394512 was registered on 11 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.47 Cr with Charge ID 100394513 was registered on 18 Apr 2020.
Charges
A charge with Punjab National Bank amounted to Rs. 8.20 Cr with Charge ID 10516918 was registered on 15 Jul 2014.
Appointed
Raj Bala Gupta was appointed as Director.
Appointed
Suresh Kumar Gupta was appointed as Director.
Incorporation
10 Jun 2013
Osper Formulations Private Limited was registered on 10 Jun 2013 with Roc Delhi & aged 13 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Osper Formulations Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Osper Formulations Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Osper Formulations Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Osper Formulations Private Limited
Osper Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AABCO8545N1Z6 | Himachal Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Osper Formulations Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osper Formulations Private Limited
Osper Formulations is an active private limited company based in Rohtak, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 June 2013 (13+ years old) and is registered under CIN U24100HR2013PTC049505.
Osper Formulations reported revenue of ₹11.03 Cr for FY 2025 (up 11% YoY).
Osper Formulations has 2 current directors:
- Suresh Kumar Gupta - Director
- Raj Bala Gupta - Director
Osper Formulations reported a net profit of ₹4.33 Lakh (net margin 0.4%) and EBITDA of ₹1.14 Cr (EBITDA margin 10.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Osper Formulations is 3% over three years and 4% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Osper Formulations is 02AABCO8545N1Z6, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Osper Formulations is U24100HR2013PTC049505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Osper Formulations has 2 court cases on record: 2 filed by the company. Most are in the high courts.
Osper Formulations was incorporated on 10 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Osper Formulations by revenue are BMW Pharmaco India Private Limited, Medicamen Life Sciences Private Limited, Rowez Life Sciences Private Limited, RN Chemicals & Pharmaceutical Private Limited, Pilco Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Raj Bala Gupta was appointed as Director on 10 Jun 2013. Suresh Kumar Gupta was appointed as Director on 10 Jun 2013.